123 related articles for article (PubMed ID: 16201909)
21. Isocitrate lyase: a potential target for anti-tubercular drugs.
Sharma R; Das O; Damle SG; Sharma AK
Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):114-23. PubMed ID: 23506018
[TBL] [Abstract][Full Text] [Related]
22. RegX3 Controls Glyoxylate Shunt and Mycobacteria Survival by Directly Regulating the Transcription of Isocitrate Lyase Gene in
Xu Y; You D; Ye BC
ACS Infect Dis; 2021 Apr; 7(4):927-936. PubMed ID: 33663204
[TBL] [Abstract][Full Text] [Related]
23. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC
Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence.
Saint-Joanis B; Demangel C; Jackson M; Brodin P; Marsollier L; Boshoff H; Cole ST
J Bacteriol; 2006 Sep; 188(18):6669-79. PubMed ID: 16952959
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
Ando H; Kitao T; Miyoshi-Akiyama T; Kato S; Mori T; Kirikae T
Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
[TBL] [Abstract][Full Text] [Related]
26. Different behaviours of promoters in Mycobacterium tuberculosis H37Rv and H37Ra.
Dokladda K; Billamas P; Palittapongarnpim P
World J Microbiol Biotechnol; 2015 Feb; 31(2):407-13. PubMed ID: 25556328
[TBL] [Abstract][Full Text] [Related]
27. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
[TBL] [Abstract][Full Text] [Related]
28. Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence.
Muñoz-Elías EJ; Upton AM; Cherian J; McKinney JD
Mol Microbiol; 2006 Jun; 60(5):1109-22. PubMed ID: 16689789
[TBL] [Abstract][Full Text] [Related]
29. The mechanism of isoniazid killing: clarity through the scope of genetics.
Vilchèze C; Jacobs WR
Annu Rev Microbiol; 2007; 61():35-50. PubMed ID: 18035606
[TBL] [Abstract][Full Text] [Related]
30. A chemical proteomics approach to profiling the ATP-binding proteome of Mycobacterium tuberculosis.
Wolfe LM; Veeraraghavan U; Idicula-Thomas S; Schürer S; Wennerberg K; Reynolds R; Besra GS; Dobos KM
Mol Cell Proteomics; 2013 Jun; 12(6):1644-60. PubMed ID: 23462205
[TBL] [Abstract][Full Text] [Related]
31. Lipid lunch for persistent pathogen.
Bishai W
Nature; 2000 Aug; 406(6797):683-5. PubMed ID: 10963578
[No Abstract] [Full Text] [Related]
32. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
[TBL] [Abstract][Full Text] [Related]
33. Active Site Flexibility of Mycobacterium tuberculosis Isocitrate Lyase in Dimer Form.
Lee YV; Choi SB; Wahab HA; Choong YS
J Chem Inf Model; 2017 Sep; 57(9):2351-2357. PubMed ID: 28820943
[TBL] [Abstract][Full Text] [Related]
34. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
[TBL] [Abstract][Full Text] [Related]
35. Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916.
Antil M; Sharma J; Brissonnet Y; Choudhary M; Gouin S; Gupta V
Int J Biol Macromol; 2019 Dec; 141():927-936. PubMed ID: 31505209
[TBL] [Abstract][Full Text] [Related]
36. Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex.
Rodrigues L; Machado D; Couto I; Amaral L; Viveiros M
Infect Genet Evol; 2012 Jun; 12(4):695-700. PubMed ID: 21871582
[TBL] [Abstract][Full Text] [Related]
37. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set.
Sun R; Converse PJ; Ko C; Tyagi S; Morrison NE; Bishai WR
Mol Microbiol; 2004 Apr; 52(1):25-38. PubMed ID: 15049808
[TBL] [Abstract][Full Text] [Related]
38. Lessons Learnt and the Way Forward for Drug Development Against Isocitrate Lyase from
Antil M; Gupta V
Protein Pept Lett; 2022; 29(12):1031-1041. PubMed ID: 36201276
[TBL] [Abstract][Full Text] [Related]
39. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
[TBL] [Abstract][Full Text] [Related]
40. Solvent isotope-induced equilibrium perturbation for isocitrate lyase.
Quartararo CE; Hadi T; Cahill SM; Blanchard JS
Biochemistry; 2013 Dec; 52(51):9286-93. PubMed ID: 24261638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
